| Last visit was: 21 Sep 2026, 05:10 |
It is currently 21 Sep 2026, 05:10 |
|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
|
Stanford GSB
Full Time MBA |
Denied without Interview
|
Round 1 | 2024 | 327 GRE | 9.1 | 5 | Technology | India |
07 Dec 2023 12:46 PM
|
|
Stanford GSB
Full Time MBA |
Denied with Interview
|
Round 1 | 2024 | 720 GMAT Classic 750 GMAT Classic |
3 | 7 | Consulting | Turkey |
07 Dec 2023 12:45 PM
|
|
McDonough
Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2024 | 690 GMAT Classic | 6.6 | 4 | Technology | India |
07 Dec 2023 12:38 PM
|
|
Stanford GSB
Full Time MBA |
Denied without Interview
|
Round 1 | 2024 | 760 GMAT Classic | 3.1 | 6 | Commercial Banking | Brazil |
07 Dec 2023 12:22 PM
|
|
Haas
Full Time MBA |
Admitted
|
Round 1 | 2024 | 760 GMAT Classic | 3.2 | 7 | Computer Software | India |
07 Dec 2023 11:55 AM
|
|
McDonough
Full Time MBA |
Admitted
|
Round 1 | 2024 | 690 GMAT Classic | 3.8 | 5 | Energy | United States |
07 Dec 2023 11:15 AM
|
|
Ross (Michigan)
Full Time MBA |
Admitted
|
Round 1 | 2024 | 690 GMAT Classic | 3.8 | 5 | Energy | United States |
07 Dec 2023 11:15 AM
|
|
Darden
Full Time MBA |
Admitted, ($)
|
Round 1 | 2024 | 730 GMAT Classic | 3.6 | 3 | Healthcare/Pharmaceuticals | India |
07 Dec 2023 11:11 AM
|
|
Stern
NYU Tech MBA |
Admitted, ($)
|
Round 1 | 2024 | 3 | Other | United States |
07 Dec 2023 11:04 AM
|
||
|
Ross (Michigan)
Full Time MBA |
Admitted, ($$$$)
|
2024 | 740 GMAT Classic | 3.2 | 7 | Consulting | Brazil |
07 Dec 2023 10:48 AM
|
|
|
Darden
Full Time MBA |
Admitted, ($)
|
2024 | 740 GMAT Classic | 3.2 | 7 | Consulting | Brazil |
07 Dec 2023 10:48 AM
|
|
|
NUS Singapore
Full Time MBA |
Denied with Interview
|
Round 1 | 2024 | 4 | Consulting | India |
07 Dec 2023 10:36 AM
|
||
|
Tepper
Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2024 | 8 | Healthcare/Pharmaceuticals | India |
07 Dec 2023 10:28 AM
|
||
|
Harvard
Full Time MBA |
Admitted
|
Round 1 | 2024 | 750 GMAT Classic | 3.7 | 5 | Finance: Venture Capital | Peru |
07 Dec 2023 09:22 AM
|
|
Ross (Michigan)
Full Time MBA |
Admitted, ($$)
|
Round 1 | 2024 | 331 GRE | 3.4 | 8 | Consulting | United States |
07 Dec 2023 09:00 AM
|
|
Ross (Michigan)
Full Time MBA |
Interviewed
|
Round 1 | 2024 | 330 GRE | 5 | Healthcare/Pharmaceuticals | India |
07 Dec 2023 08:41 AM
|
|
|
Kellogg
Full Time MBA |
Interviewed
|
Round 1 | 2024 | 330 GRE | 5 | Healthcare/Pharmaceuticals | India |
07 Dec 2023 08:41 AM
|
|
|
Booth
Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2024 | 330 GRE | 5 | Healthcare/Pharmaceuticals | India |
07 Dec 2023 08:41 AM
|
|
|
Tuck
Full Time MBA |
Admitted
|
Round 1 | 2024 | 331 GRE | 3.4 | 8 | Consulting | United States |
07 Dec 2023 08:34 AM
|
|
Said
Full Time MBA |
Interviewed
|
Round 1 | 2024 | 680 GMAT Classic 720 GMAT Classic |
3 | Consulting | India |
07 Dec 2023 08:31 AM
|